申请人:Global Blood Therapeutics, Inc.
公开号:US20150259296A1
公开(公告)日:2015-09-17
Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
本文提供了适用作为血红蛋白调节剂的化合物和药物组合物,它们的制备方法和中间体,以及在治疗由血红蛋白介导的疾病和需要组织和/或细胞氧合的疾病中使用它们的方法。